{"id":387406,"date":"2020-11-24T07:03:24","date_gmt":"2020-11-24T12:03:24","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=387406"},"modified":"2020-11-24T07:03:24","modified_gmt":"2020-11-24T12:03:24","slug":"bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/","title":{"rendered":"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference"},"content":{"rendered":"

<\/p>\n

BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference<\/b><\/p>\n

LAVAL, Quebec–(BUSINESS WIRE<\/a>)–
\nBELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (\u201cBELLUS Health\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will participate in a fireside chat at the Evercore ISI 3rd Annual Virtual HealthCONx Conference.\n<\/p>\n

Presentation Details:<\/b><\/p>\n

Event: <\/b>Evercore ISI 3rd Annual Virtual HealthCONx Conference
\n
Date: <\/b>Thursday, December 3, 2020
\n
Time:<\/b> 10:30 a.m. EST\n<\/p>\n

\nA live webcast of the fireside chat may be accessed on the Events and Presentations<\/a> page under the Investors & News section of BELLUS Health’s website at www.bellushealth.com<\/a>. Following the event, an archived webcast will be available on the Company\u2019s website.\n<\/p>\n

About BELLUS Health (<\/b>www.bellushealth.com<\/a>)<\/b><\/p>\n

\nBELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. The Company’s product candidate, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus.\n<\/p>\n

\nChronic cough, the lead indication for BLU-5937, is a cough lasting more than eight weeks and is associated with significant adverse physical, social and psychosocial effects on health and quality of life. It is estimated that approximately 26 million adults in the United States suffer from chronic cough with approximately 3 million having refractory chronic cough lasting for more than a year and approximately 6 million having refractory chronic cough lasting more than 8 weeks and under one year. There is no specific therapy approved for refractory chronic cough and current treatment options are limited.\n<\/p>\n

\nChronic pruritus, commonly known as chronic itch, is an irritating sensation that leads to scratching, and persists for longer than six weeks, which can be debilitating and has a significant impact on quality-of-life. It is a hallmark of many dermatologic disorders, including atopic dermatitis (AD). It is estimated that chronic pruritus associated with AD affects more than 16.9 million adults in the United States.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201124005310\/en\/<\/a><\/span><\/p>\n

Investors:
\n<\/b>
BELLUS Health
\n
Danny Matthews
\n
Director, Investor Relations and Communications
\n
danny@bellushealth.com<\/a><\/p>\n

Media:
\n<\/b>
Solebury Trout
\n
Julia Deutsch
\n
jdeutsch@soleburytrout.com<\/a><\/p>\n

KEYWORDS:<\/b> North America Canada<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference LAVAL, Quebec–(BUSINESS WIRE)– BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (\u201cBELLUS Health\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will participate in a fireside chat at the Evercore ISI 3rd Annual Virtual HealthCONx Conference. Presentation Details: Event: Evercore ISI 3rd Annual Virtual HealthCONx Conference Date: Thursday, December 3, 2020 Time: 10:30 a.m. EST A live webcast of the fireside chat may be accessed on the Events and Presentations page under the Investors & News section of BELLUS Health’s website at www.bellushealth.com. Following the event, … <\/p>\n

Continue reading “BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-387406","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference LAVAL, Quebec–(BUSINESS WIRE)– BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (\u201cBELLUS Health\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will participate in a fireside chat at the Evercore ISI 3rd Annual Virtual HealthCONx Conference. Presentation Details: Event: Evercore ISI 3rd Annual Virtual HealthCONx Conference Date: Thursday, December 3, 2020 Time: 10:30 a.m. EST A live webcast of the fireside chat may be accessed on the Events and Presentations page under the Investors & News section of BELLUS Health’s website at www.bellushealth.com. Following the event, … Continue reading "BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-24T12:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201124005310r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference\",\"datePublished\":\"2020-11-24T12:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/\"},\"wordCount\":390,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201124005310r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/\",\"name\":\"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201124005310r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-11-24T12:03:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201124005310r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201124005310r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/","og_locale":"en_US","og_type":"article","og_title":"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference - Market Newsdesk","og_description":"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference LAVAL, Quebec–(BUSINESS WIRE)– BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (\u201cBELLUS Health\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will participate in a fireside chat at the Evercore ISI 3rd Annual Virtual HealthCONx Conference. Presentation Details: Event: Evercore ISI 3rd Annual Virtual HealthCONx Conference Date: Thursday, December 3, 2020 Time: 10:30 a.m. EST A live webcast of the fireside chat may be accessed on the Events and Presentations page under the Investors & News section of BELLUS Health’s website at www.bellushealth.com. Following the event, … Continue reading \"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-24T12:03:24+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201124005310r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference","datePublished":"2020-11-24T12:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/"},"wordCount":390,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201124005310r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/","name":"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201124005310r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-11-24T12:03:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201124005310r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201124005310r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=387406"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387406\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=387406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=387406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=387406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}